PillCyclosporine
Brands: Cequa · Cyclosporine
1 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 7, 2023RECALLRecall (Class III): Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), R…
Subpotent: Out of Specification result observed for low assay — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide wide in the USA
- Apr 1, 2022RECALLRecall (Class III): Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) per box, Man…
Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.
- May 7, 2021RECALLRecall (Class III): Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), R…
Subpotent and Presence of Particulates . — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the US
- Feb 22, 2021RECALLRecall (Class III): Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), R…
Subpotent — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide and Australia